OBJECTIVE: To evaluate the association between serum complement levels (C3 and C4) and obstetric complications. METHODS: Fifty-seven pregnancies in primary APS (PAPS) patients were compared with 49 pregnancies in patients with UCTD and SS. A group of 175 healthy pregnant women were studied to calculate a normality range for C3 and C4 during pregnancy. Such a range was applied to define hypocomplementaemia in PAPS and UCTD/SS. RESULTS: Both groups of patients (PAPS and UCTD/SS) showed significantly lower levels of C3 and C4 in each trimester as compared with healthy women; conversely, no significant difference was found between PAPS and UCTD/SS. Comparing PAPS pregnancies with and without complications, no difference was found in the prevalence of low C3 or low C4. CONCLUSION: No association was found between hypocomplementaemia and obstetric complications in PAPS. However, both cases of pre-eclampsia were characterized by low C3 throughout pregnancy. There is evidence that the complement system is a contributor to the mechanisms of aPL-mediated damage, but its predictive role on the final pregnancy outcome does not seem to be of major impact.
Primary anti-phospholipid syndrome : any role for serum complement levels in predicting pregnancy complications? / R. Reggia, T. Ziglioli, L. Andreoli, F. Bellisai, A. Iuliano, M. Gerosa, V. Ramoni, C. Tani, A. Brucato, M. Galeazzi, M. Mosca, R. Caporali, P.L. Meroni, A. Tincani. - In: RHEUMATOLOGY. - ISSN 1462-0324. - 51:12(2012 Dec), pp. 2186-2190. [10.1093/rheumatology/kes225]
Primary anti-phospholipid syndrome : any role for serum complement levels in predicting pregnancy complications?
M. Gerosa;A. Brucato;R. Caporali;P.L. MeroniPenultimo
;
2012
Abstract
OBJECTIVE: To evaluate the association between serum complement levels (C3 and C4) and obstetric complications. METHODS: Fifty-seven pregnancies in primary APS (PAPS) patients were compared with 49 pregnancies in patients with UCTD and SS. A group of 175 healthy pregnant women were studied to calculate a normality range for C3 and C4 during pregnancy. Such a range was applied to define hypocomplementaemia in PAPS and UCTD/SS. RESULTS: Both groups of patients (PAPS and UCTD/SS) showed significantly lower levels of C3 and C4 in each trimester as compared with healthy women; conversely, no significant difference was found between PAPS and UCTD/SS. Comparing PAPS pregnancies with and without complications, no difference was found in the prevalence of low C3 or low C4. CONCLUSION: No association was found between hypocomplementaemia and obstetric complications in PAPS. However, both cases of pre-eclampsia were characterized by low C3 throughout pregnancy. There is evidence that the complement system is a contributor to the mechanisms of aPL-mediated damage, but its predictive role on the final pregnancy outcome does not seem to be of major impact.File | Dimensione | Formato | |
---|---|---|---|
Rheumatology-2012-Reggia-2186-90.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
117.95 kB
Formato
Adobe PDF
|
117.95 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.